Anti‐angiogenic activity of thienopyridine derivative LCB03‐0110 by targeting VEGFR‐2 and JAK/STAT3 Signalling

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|24|7|503-509

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.24, Iss.7, 2015-07, pp. : 503-509

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases

By  

Current Signal Transduction Therapy, Vol. 4, Iss. 3, 2009-09 ,pp. : 201-221

Bentham Science Publishers

Access to resources Recommend Favorite

A Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 6, 2015-06 ,pp. : 805-817

John Wiley & Sons Inc

Access to resources Recommend Favorite

The JAK2/STAT3 pathway is involved in the anti‐melanoma effects of atractylenolide I

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 27, Iss. 2, 2018-02 ,pp. : 201-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interleukin‐22 upregulates HB‐EGF expression in HaCaT cells via JAK2/STAT3 and ERK1/2 signalling

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 9, 2015-09 ,pp. : 713-714

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted next generation sequencing of breast implant‐associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 5, 2018-03 ,pp. : 741-744

John Wiley & Sons Inc

Access to resources Recommend Favorite